1. Home
  2. APRE vs AMST Comparison

APRE vs AMST Comparison

Compare APRE & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • AMST
  • Stock Information
  • Founded
  • APRE 2006
  • AMST 2017
  • Country
  • APRE United States
  • AMST United States
  • Employees
  • APRE N/A
  • AMST N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • AMST Computer Software: Prepackaged Software
  • Sector
  • APRE Health Care
  • AMST Technology
  • Exchange
  • APRE Nasdaq
  • AMST Nasdaq
  • Market Cap
  • APRE 9.7M
  • AMST 9.5M
  • IPO Year
  • APRE 2019
  • AMST 2020
  • Fundamental
  • Price
  • APRE $1.75
  • AMST $2.84
  • Analyst Decision
  • APRE Strong Buy
  • AMST
  • Analyst Count
  • APRE 2
  • AMST 0
  • Target Price
  • APRE $15.50
  • AMST N/A
  • AVG Volume (30 Days)
  • APRE 35.7K
  • AMST 3.4M
  • Earning Date
  • APRE 05-14-2025
  • AMST 05-15-2025
  • Dividend Yield
  • APRE N/A
  • AMST N/A
  • EPS Growth
  • APRE N/A
  • AMST N/A
  • EPS
  • APRE N/A
  • AMST N/A
  • Revenue
  • APRE $1,284,475.00
  • AMST $82,544.00
  • Revenue This Year
  • APRE N/A
  • AMST N/A
  • Revenue Next Year
  • APRE N/A
  • AMST N/A
  • P/E Ratio
  • APRE N/A
  • AMST N/A
  • Revenue Growth
  • APRE 33.27
  • AMST N/A
  • 52 Week Low
  • APRE $1.41
  • AMST $2.00
  • 52 Week High
  • APRE $5.01
  • AMST $6.27
  • Technical
  • Relative Strength Index (RSI)
  • APRE 49.51
  • AMST 54.10
  • Support Level
  • APRE $1.60
  • AMST $2.67
  • Resistance Level
  • APRE $2.00
  • AMST $3.04
  • Average True Range (ATR)
  • APRE 0.16
  • AMST 0.29
  • MACD
  • APRE 0.02
  • AMST -0.02
  • Stochastic Oscillator
  • APRE 37.50
  • AMST 21.90

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

Share on Social Networks: